Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- COTA and MedStar Health Partner To Drive Scientific Research and Expedite Delivery of Innovative Cancer Treatments
MedStar Health is proud to announce a new research partnership with COTA, Inc., an oncology real-wor... - Artificial Intelligence Predictors of Death from COVID-19
Researchers at MedStar Health led an international team that used artificial intelligence to evaluat... - MedStar Health Investigates New Algorithm for Electrical Injury Treatment
Researchers from the Firefighters’ Burn and Surgical Research Laboratory at MedStar Washington Ho...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]